Anzeige
Mehr »
Login
Dienstag, 11.08.2020 Börsentäglich über 12.000 News von 644 internationalen Medien
Massive Exploration sorgt für gewaltigen Newsflow und Neubewertung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12BHU ISIN: NL0010872420 Ticker-Symbol: A28 
Tradegate
11.08.20
20:10 Uhr
2,908 Euro
-0,375
-11,42 %
1-Jahres-Chart
AFFIMED NV Chart 1 Jahr
5-Tage-Chart
AFFIMED NV 5-Tage-Chart
RealtimeGeldBriefZeit
2,9623,01023:00
2,8013,10422:00

Aktuelle News zur AFFIMED Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
AFFIMED Aktie jetzt für 0€ handeln
17:46Affimed N.V. (AFMD) CEO Adi Hoess on Q2 2020 Results - Earnings Call Transcript6
14:10Affimed: Q2 Earnings Insights5
13:01Press Release: Affimed Reports Second Quarter 2020 Financial Results and Operational Progress147-- Continued progress in the AFM13 pTCL REDIRECT monotherapy study -- AFM24 is recruiting patients in cohort 2 of a Phase 1/2a clinical trial -- Genentech's RO7297089 is actively...
► Artikel lesen
12:35Affimed N.V. - 6-K, Report of foreign issuer1
MiAffimed N.V. - 6-K, Report of foreign issuer5
MiAffimed N.V.: Affimed Announces Two New Appointments to Its Supervisory Board5
04.08.Affimed N.V.: Affimed to Report Second Quarter 2020 Financial Results & Corporate Update August 11, 20203
27.07.Affimed N.V. - 6-K, Report of foreign issuer5
24.07.Affimed's Innate Immune Programs Offer A Compelling Value At Current Price Levels9
10.07.Affimed N.V. - 6-K, Report of foreign issuer-
10.07.Affimed N.V.: Affimed Announces Annual General Meeting of Shareholders7
01.07.Affimed: Updates To Thesis, Time To Gain Exposure To Innate Immuno-Oncology17
29.06.Hedge Funds Have Never Been This Bullish On Affimed NV (AFMD)13
23.06.Affimed N.V. (AFMD) CEO Adi Hoess on Q1 2020 Results - Earnings Call Transcript16
23.06.Affimed: Q1 Earnings Insights5
23.06.Affimed N.V. - 6-K, Report of foreign issuer2
23.06.Affimed EPS beats by €0.01, beats on revenue4
23.06.Affimed N.V.: Affimed Reports First Quarter 2020 Financial Results and Operational Progress9
22.06.Affimed N.V.: Affimed Announces Presentation of Data on Genentech's RO7297089 and AFM24, Both Innate Cell Engagers Developed from Affimed's ROCK Platform, ...33
17.06.BRIEF-Affimed NV Says Announced Completion Of First Dose Cohort In Phase 1/2A Clinical Trial Of AFM248
Seite:  Weiter >>
50 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1